Generative AI technologies like OpenAI’s ChatGPT have the potential to transform the landscape of psychiatric practices and patient engagement. That makes it crucial for the psychiatric community to think proactively about the role that AI can play in the field of mental health—and partner with parties driving AI innovation.

The authors discuss the two broad domains of affect-focused and exposure-focused psychotherapies, defining the characteristics and potential advantages and disadvantages of each. The two domains differ in their theoretical approaches, structures, and techniques.

Alzheimer's disease is a common neurodegenerative disease affecting millions of Americans and their families. Presenters Pallavi Joshi, D.O. and Ganesh Gopalakrishna, M.D., will elaborate on the advances in biomarker and imaging research and review novel and upcoming therapeutic advances in Alzheimer’s disease treatment. They will also provide guidance on their applications in clinical practice. 1.5 AMA PRA Category 1 Credits™ Learn more and register